The Food and Drug Administration (FDA) has granted authorization for the updated Novavax COVID-19 vaccine to provide protection against hospitalizations and deaths caused by circulating variants of the virus. This recent development offers a protein-based alternative, in line with the FDA’s requirements for targeting the XBB.1.5 strain, for the 2023-2024 season. Following last month’s approvals
Health
Neurofibromatosis type 1 (NF1) is a complex genetic disorder that manifests in various ways. However, the recent case of a 38-year-old woman with NF1 developing choroidal Yasunari nodules in both eyes puzzled Danish clinicians. With no prior history of systemic vasculopathy but a long-standing peripheral retinal capillary nonperfusion affecting her left eye, the patient’s condition
In a recent study, researchers found that stereotactic ablative body radiotherapy (SABR) was highly effective in treating primary renal cell carcinoma (RCC) in patients who were considered medically inoperable or high risk. The study, known as the FASTRACK II trial, showed that SABR resulted in no local progression of kidney cancer and a 100% cancer-specific
The rise in obesity rates among children and adolescents in the United States has sparked a growing interest in finding effective treatment options. While there has been extensive coverage on anti-obesity medications for adults, their use and cost-effectiveness for the younger population have received less attention. In response to this gap, the American Academy of
The news of Senator Dianne Feinstein’s passing at the age of 90 has left a void in the political landscape. Senator Feinstein, a staunch advocate for reproductive rights and champion of progressive healthcare causes, dedicated her life to fighting for the betterment of society. Her tireless efforts and indomitable spirit have left an indelible mark
In recent years, the healthcare landscape for the LGBTQ+ community has garnered significant attention. While many headlines focus on the restrictions and bans on gender-affirming care, the reality is that the health disparities faced by LGBTQ+ individuals run much deeper. While there has been progress in expanding access to transgender care in certain states, the
In a world where cancer remains one of the leading causes of premature death among women, a Lancet Commission report sheds light on the global disparities that hinder women’s access to cancer prevention, detection, and care. The report identifies gender inequalities and discrimination as key factors impeding women’s chances of avoiding cancer risk factors and
Long COVID has been a topic of great concern since the beginning of the COVID-19 pandemic. It refers to the presence of symptoms that persist for at least three months after a COVID-19 infection. A recent data analysis conducted by the CDC’s National Center for Health Statistics (NCHS) sheds light on the prevalence of long
Long COVID has been a concern for individuals who have been infected with the virus and experienced lingering symptoms for an extended period. Recent data from the CDC’s National Center for Health Statistics (NCHS) provides insights into the prevalence of long COVID among children and adults in the United States. The findings reveal that while
The investigational amyotrophic lateral sclerosis (ALS) treatment debamestrocel, also known as MSC-NTF or NurOwn, developed by BrainStorm Cell Therapeutics, is facing serious concerns from FDA reviewers ahead of an advisory committee meeting. The FDA has raised significant issues regarding the effectiveness and manufacturing quality of the drug, stating that the initial submission was scientifically incomplete